MEDANTA · Healthcare
Global Health Ltd. reported revenue of ₹926 cr for July to September 2025, — on the year and — on the quarter.
Operating profit (EBITDA) was ₹193 cr, a margin of 20.8%, — on the year and — on the quarter.
Net profit was ₹140 cr, — on the year and — on the quarter, with earnings per share of ₹5.22.
A hospital chain grows by filling beds and lifting revenue per bed. New hospitals dilute margins in their first years, so a margin dip during expansion is not on its own a sign of weakness. The quarterly statements do not carry occupancy, revenue per occupied bed and new beds added; those come with the filing read.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow filed with this quarter, the auditor's review, segment results, one-off items line by line and what management said on the call.
No check fired. That is a statement about the checks below, not a verdict on the company.
Could not run on this quarter: Headline vs core profit, Operating margin on the year, Depreciation falling, Finance cost rising, Swing to loss or profit, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
This quarter's filing carries a balance sheet and a cash flow statement. The cash, receivables and borrowing checks run once the filing read is in.
| Metric | Q2 FY26 |
|---|---|
| Operational beds | 3,435 |
| Occupancy | 63.7% |
| ARPOB (₹/day) | 2.01 |
| ALOS (days) | 3.06 |
| Cash and insurance share | 56% |
Read using the Hospitals framework (named in the filing read). Primary valuation lens: EV/EBITDA, mature and new hospitals separately.
Read more closely in this sector: New-hospital losses against mature margin · Government scheme receivables.
| Q2 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|
| Revenue | ₹926 cr | ₹1,079 cr | ₹1,208 cr |
| YoY | — | — | +30% |
| EBITDA margin | 20.8% | 21.3% | 24.0% |
| Other income, % of PBT | 12% | 13% | 11% |
| Exceptional items | ₹16.0 cr | — | — |
| Tax rate | 24% | 25% | 25% |
| Net profit | ₹140 cr | ₹137 cr | ₹181 cr |
| YoY | — | — | +29% |
| Core profit YoY | — | — | +48% |
| EPS | ₹5.22 | ₹5.11 | ₹6.75 |
| Flags | · | · | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Global Health Ltd. reported revenue of ₹926 cr (— on the year) and net profit of ₹140 cr (— on the year) for July to September 2025.
None of the 3 checks that could run raised a question.
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.